Rocuronium bromide and Nimbex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocuronium bromide (rocuronium bromide) and Nimbex (cisatracurium besylate). Common drug interactions include stevens-johnson syndrome among females and erythema among males.

The phase IV clinical study analyzes what interactions people have when they take Rocuronium bromide and Nimbex. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Rocuronium bromide?

Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.

On Aug, 03, 2026

48 people who take Rocuronium bromide and Nimbex together, and have interactions are studied.

Rocuronium bromide and Nimbex drug interactions.

What are the common drug interactions of Rocuronium Bromide and Nimbex, by gender? *:

female:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Pleural effusion (water on the lungs)
Septic shock (shock due to blood infection)
Anuria (failure of the kidneys to produce urine)
Toxic skin eruption (skin breakdown due to toxic substance)
Acute respiratory distress syndrome
Gamma-glutamyltransferase increased
Hepatocellular injury (liver injury)
Renal failure (kidney dysfunction)
Respiratory distress (difficulty in breathing)

male:

Erythema (redness of the skin)
Hypotension (abnormally low blood pressure)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Death
Respiratory rate decreased (less breathing rate/min)
Emotional distress
Stress
Cardiac disorder

What are the common drug interactions of Rocuronium Bromide and Nimbex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Pleural effusion (water on the lungs)
Septic shock (shock due to blood infection)
Anuria (failure of the kidneys to produce urine)
Toxic skin eruption (skin breakdown due to toxic substance)
Acute respiratory distress syndrome
Renal failure (kidney dysfunction)
Respiratory distress (difficulty in breathing)
Bacteroides infection (infection of bacteroides-a genus of gram-negative, bacillus bacteria)
Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)

50-59:

Gamma-glutamyltransferase increased
Hepatocellular injury (liver injury)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Fear
Injury
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)

60+:

Erythema (redness of the skin)
Hypotension (abnormally low blood pressure)
Multi-organ failure (multisystem organ failure)
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Stress
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Periorbital oedema (swelling around the eyes)

What are the existing conditions these people have? *

Anaesthesia: 13 people, 27.08%
Pain: 13 people, 27.08%
Type 2 Diabetes: 12 people, 25.00%
Infection: 10 people, 20.83%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 20.83%
General Anaesthesia: 10 people, 20.83%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 10 people, 20.83%
High Blood Pressure: 10 people, 20.83%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 20.83%
Oesophagitis (inflammation of oesophagus): 8 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rocuronium bromide and Nimbex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously